121 related articles for article (PubMed ID: 37733700)
1. A novel rapid detection method for a single-nucleotide substitution mutation derived from canine urothelial and prostatic carcinoma cells present in small amounts in urine sediments.
Okumura S; Ohsato Y
PLoS One; 2023; 18(9):e0286229. PubMed ID: 37733700
[TBL] [Abstract][Full Text] [Related]
2. Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma.
Mochizuki H; Shapiro SG; Breen M
PLoS One; 2015; 10(12):e0144170. PubMed ID: 26649430
[TBL] [Abstract][Full Text] [Related]
3. BRAF
Maeda S; Yoshitake R; Chambers JK; Uchida K; Eto S; Ikeda N; Nakagawa T; Nishimura R; Goto-Koshino Y; Yonezawa T; Momoi Y
Vet Pathol; 2021 Sep; 58(5):971-980. PubMed ID: 33205710
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of the BRAF variant V595E in urine samples, smears and biopsies from canine transitional cell carcinoma].
Aupperle-Lellbach H; Grassinger J; Hohloch C; Kehl A; Pantke P
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):289-295. PubMed ID: 30541168
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption.
Thomas R; Wiley CA; Droste EL; Robertson J; Inman BA; Breen M
PLoS Genet; 2023 Apr; 19(4):e1010575. PubMed ID: 37079639
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the BRAF V595E mutation in plasma cell-free DNA from dogs with urothelial carcinoma.
Tagawa M; Tambo N; Maezawa M; Tomihari M; Watanabe KI; Inokuma H; Miyahara K
PLoS One; 2020; 15(4):e0232365. PubMed ID: 32330187
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Canine Transitional Cell Carcinoma Cell Lines Harboring BRAF V595E Mutation as a Therapeutic Target.
Jung H; Bae K; Lee JY; Kim JH; Han HJ; Yoon HY; Yoon KA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502061
[TBL] [Abstract][Full Text] [Related]
8. BRAF Mutations in Canine Cancers.
Mochizuki H; Kennedy K; Shapiro SG; Breen M
PLoS One; 2015; 10(6):e0129534. PubMed ID: 26053201
[TBL] [Abstract][Full Text] [Related]
9. Sequence analysis of RAS and RAF mutation hot spots in canine carcinoma.
Mochizuki H; Breen M
Vet Comp Oncol; 2017 Dec; 15(4):1598-1605. PubMed ID: 27714944
[TBL] [Abstract][Full Text] [Related]
10. Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF
Wang Z; Sun K; Jing C; Cao H; Ma R; Wu J
J Clin Lab Anal; 2019 Jul; 33(6):e22902. PubMed ID: 31021028
[TBL] [Abstract][Full Text] [Related]
11. Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid.
Kaji K; Yonezawa T; Momoi Y; Maeda S
Animals (Basel); 2022 Feb; 12(4):. PubMed ID: 35203195
[TBL] [Abstract][Full Text] [Related]
12. Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma.
Peralta S; Webb SM; Katt WP; Grenier JK; Duhamel GE
Vet Comp Oncol; 2023 Mar; 21(1):138-144. PubMed ID: 36451536
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence to Predict the BRAF V595E Mutation in Canine Urinary Bladder Urothelial Carcinomas.
Küchler L; Posthaus C; Jäger K; Guscetti F; van der Weyden L; von Bomhard W; Schmidt JM; Farra D; Aupperle-Lellbach H; Kehl A; Rottenberg S; de Brot S
Animals (Basel); 2023 Jul; 13(15):. PubMed ID: 37570213
[TBL] [Abstract][Full Text] [Related]
14. Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma.
Harris T; Sheel A; Zong Y; Hutchinson LM; Cornejo KM; Bubendorf L; Yates J; Fischer AH
J Am Soc Cytopathol; 2021; 10(1):94-102. PubMed ID: 33184010
[TBL] [Abstract][Full Text] [Related]
15. BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006-2019).
Gedon J; Kehl A; Aupperle-Lellbach H; von Bomhard W; Schmidt JM
Vet Comp Oncol; 2022 Jun; 20(2):449-457. PubMed ID: 34878687
[TBL] [Abstract][Full Text] [Related]
16. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
[TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.
Decker B; Parker HG; Dhawan D; Kwon EM; Karlins E; Davis BW; Ramos-Vara JA; Bonney PL; McNiel EA; Knapp DW; Ostrander EA
Mol Cancer Res; 2015 Jun; 13(6):993-1002. PubMed ID: 25767210
[TBL] [Abstract][Full Text] [Related]
20. Validation of a Liquid Biopsy Protocol for Canine BRAFV595E Variant Detection in Dog Urine and Its Evaluation as a Diagnostic Test Complementary to Cytology.
Gentilini F; Palgrave CJ; Neta M; Tornago R; Furlanello T; McKay JS; Sacchini F; Turba ME
Front Vet Sci; 2022; 9():909934. PubMed ID: 35711804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
